BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12003579)

  • 1. Multivariate analyses to assess treatment effectiveness in advanced head and neck cancer.
    Patel U; Spitznagel E; Piccirillo J
    Arch Otolaryngol Head Neck Surg; 2002 May; 128(5):497-503. PubMed ID: 12003579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Surgery/Radiotherapy in Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Population-Based Approach.
    Patel TD; Marchiano E; Chin OY; Kilic S; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 May; 154(5):868-74. PubMed ID: 26884368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
    George JR; Yom SS; Wang SJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
    Gleich LL; Collins CM; Gartside PS; Gluckman JL; Barrett WL; Wilson KM; Biddinger PW; Redmond KP
    Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):26-35. PubMed ID: 12525191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
    Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
    Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
    Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.
    Rosenthal DI; Liu L; Lee JH; Vapiwala N; Chalian AA; Weinstein GS; Chilian I; Weber RS; Machtay M
    Head Neck; 2002 Feb; 24(2):115-26. PubMed ID: 11891941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
    Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.
    Ang KK; Trotti A; Brown BW; Garden AS; Foote RL; Morrison WH; Geara FB; Klotch DW; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):571-8. PubMed ID: 11597795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma.
    Makita C; Kodaira T; Daimon T; Tachibana H; Tomita N; Koide Y; Koide Y; Fukuda Y; Nishikawa D; Suzuki H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2017 Dec; 47(12):1141-1150. PubMed ID: 29036621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J; Domenge C; Ozsahin M; Matuszewska K; Lefèbvre JL; Greiner RH; Giralt J; Maingon P; Rolland F; Bolla M; Cognetti F; Bourhis J; Kirkpatrick A; van Glabbeke M;
    N Engl J Med; 2004 May; 350(19):1945-52. PubMed ID: 15128894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis.
    Lundahl RE; Foote RL; Bonner JA; Suman VJ; Lewis JE; Kasperbauer JL; McCaffrey TV; Olsen KD
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):529-34. PubMed ID: 9486600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
    Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments.
    Evers C; Ostheimer C; Sieker F; Vordermark D; Medenwald D
    PLoS One; 2020; 15(2):e0229266. PubMed ID: 32101560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.